Pfizer, Kaiser End Neurontin Off-Label Suit With Fee Deal
Pfizer Inc. agreed on Wednesday to settle the remaining claims for attorneys' fees in Kaiser Foundation Health Plan Inc.'s suit against the drugmaker in multidistrict litigation over the allegedly deceptive marketing...To view the full article, register now.
Already a subscriber? Click here to view full article